Llamas: leading the pack in new cancer therapy

Llama antibodies - known as VHHs or nanobodies - could be a gamechanger for precision medicine. Marion Cubitt, Director of Discovery at Isogenica, explains how an accidental discovery opened a fresh pathway for immunotherapy. Tell...

Breaking boundaries in bio manufacturing

Eric Fua, Conference Producer, IMAPAC UK, investigates the challenges and opportunities facing the biomanufacturing industry. Last year, the global biomanufacturing market surged to an astounding US$19.02 billion, signifying the sector’s potential to revolutionise global health.1 Biopharmaceutical...

The changing face of cancer care

Breast cancer patients could be spared unnecessary chemotherapy thanks to a new gene test. Karen Southern chats to surgical oncologist, Prof Simon Holt, about how genomic breakthroughs like Oncotype DX are transforming UK cancer...

Advanced testing is vital to prevent bird flu pandemic

Is the UK prepared for a potential bird flu epidemic among humans? The answer is no, says influenza virologist and lecturer, Dr Nicole Robb. The odds of a bird - or avian - flu outbreak...

Defining the future of experiment design

Synthace is a biotech start-up accelerating biological discovery and optimisation through computer-aided biology. CEO Guy Levy-Yurista tells Bioscience Today why this is the decade when life sciences’ biggest challenges will be solved - in...

Next-generation biologics: today’s reality

Shark molecules provide the basis of unique new therapeutics which could transform the treatment of inflammatory diseases and cancer. Karen Southern talks to Dr Caroline Barelle, CEO and founder of Elasmogen, the small biopharmaceutical...

T cells: their increasing significance in infectious disease diagnosis and research

Peter Wrighton-Smith, CEO of Oxford Immunotec, talks to Bioscience Today about growing understanding of the importance of T cells in protecting us from disease, as well as their critical role in measuring immune responses...

Biotech pioneer tackles the biology of ageing

Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen...

Biosample provenance: what researchers need to know

Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates. The journey for every biospecimen used for...

SAGES TEACH THE ART OF ADAPTING TO CLIMATE CHANGE

While the conversation about climate change has been dominated by mitigation, what is equally crucial is the need to adapt to the unavoidable changes already on their way. “We have absolutely no choice but...

PROFESSOR HONOURED FOR HER WORK ON PANDEMIC CONTROL

A Women in Science event held earlier this year demonstrated that women are certainly coming into their own in the fields of science, technology, engineering and maths. In this, the final feature in a three-part...

THE ROAD LESS TRAVELLED

A Women in Science event that took place in Newcastle upon Tyne’s Biosphere business incubator earlier this year certainly demonstrated that women are finally coming into their own in the fields of science, technology,...

TABBY CAT OR TIGER?

Medics need to be fleet of foot when it comes to determining whether they are dealing with something tame or wild, but the traditional route to identifying bacteria takes time. Now a team of...

Life Science success

Whilst the recent past has been one of huge uncertainty with regards to the political and economic landscape across the globe, the past year saw major success in Life Sciences & Healthcare across the...

Nobel prize winner talks to us

Dr Frances Arnold, the American chemist and engineer who won the 2018 Nobel Prize in Chemistry and the 2016 Millennium Technology Prize for her work in pioneering directed evolution reveals more about her work.  Dr...

Making clinical trials right for older people

In this issue, we speak to Miles Witham, Professor of Trials for Older People at Newcastle University and consultant geriatrician, about why he’s bringing about a sea change in how clinical trials involving older...